Orally administered emu oil attenuates clinical indicators of disease in a mouse model of acute Crohn's disease

被引：0
|
作者：
Mitchell, C. J. [1 ,2 ]
Howarth, G. S. [1 ,2 ,3 ]
Chartier, L. C. [1 ,2 ]
Trinder, D. [4 ,5 ]
Lawrance, I. C. [4 ,6 ]
Mashtoub, S. [1 ,3 ,4 ]
机构：
[1] Womens & Childrens Hosp, Dept Gastroenterol, Adelaide, SA, Australia
[2] Univ Adelaide, Sch Anim & Vet Sci, Adelaide, SA, Australia
[3] Univ Adelaide, Adelaide Med Sch, Adelaide, SA, Australia
[4] Univ Western Australia, Sch Med, Fiona Stanley Hosp, Perth, WA, Australia
[5] Harry Perkins Inst Med Res, Perth, WA, Australia
[6] St John God Hosp, Ctr Inflammatory Bowel Dis, Perth, WA, Australia
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2018年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：83 / 84
页数：2
相关论文
共 50 条
  • [21] EMU OIL ATTENUATES DISEASE SEVERITY AND RESULTS IN FEWER LARGE COLONIC TUMOURS IN A MOUSE MODEL OF COLITIS-ASSOCIATED COLORECTAL CANCER
    Mashtoub, Suzanne
    Howarth, Gordon S.
    Trinder, Debbie
    Lawrance, Ian
    GASTROENTEROLOGY, 2017, 152 (05) : S737 - S737
  • [22] Risk Prediction Model for Crohn's Disease Based on Hematological Indicators
    Zeng, Tao
    Xiao, Yushan
    Huang, Zhongchao
    Wang, Xianghui
    Hu, Suhua
    Huang, Jiahui
    Liu, Huanliang
    CLINICAL LABORATORY, 2023, 69 (07) : 1434 - 1442
  • [23] Acute pancreatitis in Crohn's disease: Clinical features and outcomes
    Moolsintong, P
    Loftus, EV
    Chari, ST
    Egan, LJ
    Tremaine, WJ
    Sandborn, WJ
    GASTROENTEROLOGY, 2003, 124 (04) : A399 - A399
  • [24] Defective acute inflammation in Crohn's disease: a clinical investigation
    Marks, DJB
    Harbord, MWN
    MacAllister, R
    Rahman, FZ
    Young, J
    Al-Lazikani, B
    Lees, W
    Novelli, M
    Bloom, S
    Segal, AW
    LANCET, 2006, 367 (9511): : 668 - 678
  • [25] Astaxanthin Attenuates Neurotoxicity in a Mouse Model of Parkinson's Disease
    Grimmig, B.
    Daly, L.
    Hudson, C.
    Bickford, P. C.
    CELL TRANSPLANTATION, 2016, 25 (04) : 759 - 759
  • [26] Assessing intestinal permeability in Crohn's disease patients using orally administered 52Cr-EDTA
    von Martels, Julius Z. H.
    Bourgonje, Arno R.
    Harmsen, Hermie J. M.
    Faber, Klaas Nico
    Dijkstra, Gerard
    PLOS ONE, 2019, 14 (02):
  • [27] Disulfiram enhanced delivery of orally administered copper into the central nervous system in Menkes disease mouse model
    Hoshina, Takao
    Nozaki, Satoshi
    Hamazaki, Takashi
    Kudo, Satoshi
    Nakatani, Yuka
    Kodama, Hiroko
    Shintaku, Haruo
    Watanabe, Yasuyoshi
    JOURNAL OF INHERITED METABOLIC DISEASE, 2018, 41 (06) : 1285 - 1291
  • [28] A clinical and radiographic model to predict surgery for acute small bowel obstruction in Crohn’s disease
    Sarina C. Lowe
    Justin Ream
    David Hudesman
    Lisa Malter
    Brian Bosworth
    Yuhe Xia
    Hua Zhong
    Bari Dane
    Alec Megibow
    Shannon Chang
    Abdominal Radiology, 2020, 45 : 2663 - 2668
  • [29] A clinical and radiographic model to predict surgery for acute small bowel obstruction in Crohn's disease
    Lowe, Sarina C.
    Ream, Justin
    Hudesman, David
    Malter, Lisa
    Bosworth, Brian
    Xia, Yuhe
    Zhong, Hua
    Dane, Bari
    Megibow, Alec
    Chang, Shannon
    ABDOMINAL RADIOLOGY, 2020, 45 (09) : 2663 - 2668
  • [30] AT1R blocker losartan attenuates intestinal epithelial cell apoptosis in a mouse model of Crohn's disease
    Liu, Tian-Jing
    Shi, Yong-Yan
    Wang, En-Bo
    Zhu, Tong
    Zhao, Qun
    MOLECULAR MEDICINE REPORTS, 2016, 13 (02) : 1156 - 1162
12345